An endotracheal tube with antimicrobial coating proposed to reduce risk for ventilator-associated pneumonia in hospitalized patients under anesthesia, and in cases where the duration of intubation is unpredictable or expected to last at least 24 hours.
Horizon Scanning
It is a challenge for health plans and clinicians to know what emerging technologies are in the preapproval phase and what their clinical, financial, and risk impacts might be. This is where we come in.The Hayes Horizon Scanning Solution identifies innovative and potentially disruptive health technologies that are in various stages of the regulatory approval process. Our Research Analysts continually investigate new technologies that are on the horizon or in the early stages of clinical investigation, as well as the testing of existing technologies that may be seeking approval for new clinical applications. Hayes Horizon Scanning helps you track emerging technologies before you need to make decisions. Accessed through the Hayes Knowledge Center, Hayes Horizon Scanning addresses the following fundamental questions to help our clients forecast emerging technologies:
- Is this emerging technology new or replacing an existing technology?
- Where is this technology in the FDA regulatory process?
- When will this technology be commercially available in the market?
- What is the projected use, cost, and financial impact of this technology?
EYESi® Ophthalmologic Surgery Simulator
A virtual-reality surgical training system for vitreoretinal and cataract procedures.
Sulonex (Sulodexide Oral Gelcap)
An oral heparinoid compound for the treatment of diabetic nephropathy.
IOL-Vip (Intraocular Lens for Visually Impaired People) System
A monocular, double intraocular lens telescopic implant that provides visual magnification to patients with macular degeneration.
Iclaprim (AR-100)
An intravenous antibiotic for the treatment of hospitalized patients with complicated skin and skin structure infections, including those caused by methicillin-resistant Staphylococcus aureus.
Ablatherm® High-Intensity Focused Ultrasound (HIFU) System
A high-intensity focused ultrasound system that utilizes an endorectal probe to heat and destroy pathogenic tissue associated with prostate cancer.
Sonablate® 500 High-Intensity Focused Ultrasound (HIFU) System
A high-intensity focused ultrasound system that utilizes an endorectal probe to heat and destroy pathogenic tissue associated with prostate cancer.
eSensor® XT-8 2C9/VKOR Genotyping Test for Warfarin Sensitivity
An automated genotyping system to prospectively identify which patients may be at increased risk for a severe bleeding event among those with a genetic predisposition to warfarin sensitivity. The test is performed in just over 4 hours.
XIENCE™ V Everolimus-Eluting Stent
An everolimus-eluting stent consisting of the Multi-Link Vision® cobalt chromium stent platform coated with a hemocompatible durable polymer and everolimus, intended for use in de novo native coronary artery lesions in patients with symptomatic coronary artery disease.
Entereg® (Alvimopan)
An oral drug for the treatment of postoperative ileus, indicated for inpatient use only in adult patients undergoing partial large or small bowel resection surgery.